Systems Biology: New Approaches to Old Environmental Health Problems

The environment plays a pivotal role as a human health determinant and presence of hazardous pollutants in the environment is often implicated in human disease. That pollutants cause human diseases however is often controversial because data connecting exposure to environmental hazards and human diseases are not well defined, except for some cancers and syndromes such as asthma. Understanding the complex nature of human-environment interactions and the role they play in determining the state of human health is one of the more compelling problems in public health. We are becoming more aware that the reductionist approach promulgated by current methods has not, and will not yield answers to the broad questions of population health risk analysis. If substantive applications of environment-gene interactions are to be made, it is important to move to a systems level approach, to take advantage of epidemiology and molecular genomic advances. Systems biology is the integration of genomics, transcriptomics, proteomics, and metabolomics together with computer technology approaches to elucidate environmentally caused disease in humans. We discuss the applications of environmental systems biology as a route to solution of environmental health problems.

[1]  Illtyd Trethowan Causality , 1938 .

[2]  R. Franklin,et al.  Molecular Configuration in Sodium Thymonucleate , 1953, Nature.

[3]  J. Seegmiller Genetic and molecular basis of human hereditary diseases. , 1967, Clinical chemistry.

[4]  F. Crick Central Dogma of Molecular Biology , 1970, Nature.

[5]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1974, Nature.

[6]  M. O. Dayhoff,et al.  Protein and Nucleic Acid Sequence Database Systems. , 1983, Annual review of biophysics and bioengineering.

[7]  Division on Earth Risk Assessment in the Federal Government: Managing the Process , 1983 .

[8]  J. Deegan Looking back at love canal. , 1987, Environmental science & technology.

[9]  A. Prost [From disease to health: the individual, society, environment and culture]. , 1995, Sante.

[10]  M. Vegetti [Law and nature in the Hippocratic treatise De aëre]. , 1995, Medicina nei secoli.

[11]  Gerald L. Geison The Private Science of Louis Pasteur , 1995 .

[12]  The sad and tragic life of Typhoid Mary. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[13]  S. Sturdy The private science of Louis Pasteur , 1996, Medical History.

[14]  Allan Mazur A Hazardous Inquiry: The Rashomon Effect at Love Canal , 1998 .

[15]  A. Frank A Hazardous Inquiry: The Rashomon Effect at Love Canal , 1998 .

[16]  C. A. Millán Graeco-Roman case histories and their influence on Medieval Islamic clinical accounts. , 1999 .

[17]  W P Bennett,et al.  Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer , 1999, The Journal of pathology.

[18]  C. Álvarez Millán Graeco-Roman case histories and their influence on Medieval Islamic clinical accounts. , 1999, Social history of medicine : the journal of the Society for the Social History of Medicine.

[19]  D. Bentley The Human Genome Project--an overview. , 2000, Medicinal research reviews.

[20]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[21]  C. Poole,et al.  Looking back on "causal thinking in the health sciences". , 2000, Annual review of public health.

[22]  Genetic Polymorphisms and Susceptibility to Disease , 2000 .

[23]  K. Olden,et al.  Genomics: implications for toxicology. , 2001, Mutation research.

[24]  P. Pharoah Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease , 2001, BMJ : British Medical Journal.

[25]  A. Baxter Louis Pasteur's beer of revenge , 2001, Nature Reviews Immunology.

[26]  I. Day,et al.  Epidemiology and the genetic basis of disease. , 2001, International journal of epidemiology.

[27]  J C Anthony,et al.  The promise of psychiatric enviromics. , 2001, The British journal of psychiatry. Supplement.

[28]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[29]  Christopher J Portier,et al.  Toxicogenomics: the new frontier in risk analysis. , 2002, Carcinogenesis.

[30]  S. Greenland,et al.  Estimating causal effects. , 2002, International journal of epidemiology.

[31]  M. Rothstein,et al.  On the edge of tomorrow: fitting genomics into public health policy. , 2002, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[32]  Richard Judson,et al.  How many SNPs does a genome-wide haplotype map require? , 2002, Pharmacogenomics.

[33]  Genomics versus orphan nuclear receptors--a half-time report. , 2002, Molecular endocrinology.

[34]  B. Shastry,et al.  SNP alleles in human disease and evolution , 2002, Journal of Human Genetics.

[35]  Alfonso Valencia,et al.  Early bioinformatics: the birth of a discipline - a personal view , 2003, Bioinform..

[36]  M. Frazier,et al.  Realizing the Potential of the Genome Revolution: The Genomes to Life Program , 2003, Science.

[37]  W. Grody Molecular genetic risk screening. , 2003, Annual review of medicine.

[38]  F. Collins,et al.  The Human Genome Project: Lessons from Large-Scale Biology , 2003, Science.

[39]  Michael Dean,et al.  Approaches to identify genes for complex human diseases: Lessons from Mendelian disorders , 2003, Human mutation.

[40]  T. Zacharewski,et al.  Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  F. Levy,et al.  The potential impact of genetic sequencing on the American health insurance system. , 2003, Journal of health care law & policy.

[42]  P. Rabinowitz,et al.  Host-environment medicine: a primary care model for the age of genomics. , 2003, Journal of general internal medicine.

[43]  E. Clayton Ethical, legal, and social implications of genomic medicine. , 2003, The New England journal of medicine.

[44]  K. Sakurai,et al.  Application of Toxicogenomic Analysis to Risk Assessment of Delayed Long-Term Effects of Multiple Chemicals Including Endocrine Disruptors in Human Fetuses , 2003, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.

[45]  T. Brüning,et al.  Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. , 2003, International journal of hygiene and environmental health.

[46]  N. Risch,et al.  Genomic Priorities and Public Health , 2003, Science.

[47]  J. Waller The Discovery of the Germ: Twenty Years That Transformed the Way We Think About Disease , 2003 .

[48]  P. Elliott,et al.  Evaluating evidence on environmental health risks. , 2003, British medical bulletin.

[49]  T. Colborn,et al.  Neurodevelopment and Endocrine Disruption , 2003, Environmental health perspectives.

[50]  P. Thomas,et al.  Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Fisher,et al.  Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. , 2004, Reproduction.

[52]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[53]  Christopher P Austin,et al.  The impact of the completed human genome sequence on the development of novel therapeutics for human disease. , 2004, Annual review of medicine.

[54]  L. Roberts Polio endgame. The exit strategy. , 2004, Science.

[55]  L. Roberts Polio: The Final Assault? , 2004, Science.

[56]  J. Ferretti,et al.  Comparative genomics of streptococcal species. , 2004, The Indian journal of medical research.

[57]  S. Primrose,et al.  Genomics: Applications in Human Biology , 2004 .

[58]  T. Fujii Transgenerational effects of maternal exposure to chemicals on the functional development of the brain in the offspring , 1997, Cancer Causes & Control.

[59]  K. Olden Genomics in environmental health research--opportunities and challenges. , 2004, Toxicology.

[60]  T. Yamanaka,et al.  Gene Interaction Network Suggests Dioxin Induces a Significant Linkage between Aryl Hydrocarbon Receptor and Retinoic Acid Receptor Beta , 2004, Environmental health perspectives.

[61]  L. Roberts The Exit Strategy , 2004, Science.

[62]  T. John The golden jubilee of vaccination against poliomyelitis. , 2004, The Indian journal of medical research.

[63]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[64]  S. Chanock,et al.  SNPs in cancer research and treatment , 2004, British Journal of Cancer.

[65]  David R. Bentley,et al.  Genomes for medicine , 2004, Nature.

[66]  Ortwin Renn,et al.  Perception of risks. , 2004, Toxicology letters.

[67]  Philippe Grandjean,et al.  Implications of the precautionary principle for primary prevention and research. , 2004, Annual review of public health.

[68]  Francis S. Collins,et al.  The case for a US prospective cohort study of genes and environment , 2004, Nature.

[69]  P. Lescuyer,et al.  Biomedical Applications of Proteomics , 2004 .

[70]  Dana C Crawford,et al.  Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. , 2004, American journal of human genetics.

[71]  K. Kelsey,et al.  Genetic susceptibility to environmental and occupational cancers , 1997, Cancer Causes & Control.